Product Information
ENALAPRIL MALEATE 5 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0724 per EA under NDC 43547054611. Its NADAC has been published 210 times since Sep 28, 2022.
FDA first approved this application on Jul 7, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547054611
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ENALAPRIL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA213273FDA Approved
7/7/2022
TE Code
AB
On Market Since
7/31/2022
Pharmacological Classes
Price Statistics
The NADAC for ENALAPRIL MALEATE 5 MG TABLET has been published 210 times since Sep 28, 2022, and over the history we have for it it has declined 38.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0724 per EA |
|---|---|
| All-time high | $0.1252 (Nov 16, 2022) |
| All-time low | $0.0693 (May 22, 2024) |
| 52-week high | $0.0819 |
| 52-week low | $0.0709 |
| Median price | $0.0790 |
| Average price | $0.0867 |
| Largest weekly change | +58.6% (Apr 19, 2023) |
| Weeks tracked | 210 |
| Tracking since | Sep 28, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Solco Healthcare US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Enalapril Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENALAPRIL MALEATE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ENALAPRIL MALEATE 5 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0724 per EA (NDC 43547054611), effective Sep 30, 2026.
How has the price of ENALAPRIL MALEATE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ENALAPRIL MALEATE 5 MG TABLET has declined 38.3%. It has been tracked across 210 weekly CMS publications since Sep 28, 2022.
What are the highest and lowest recorded NADAC prices for ENALAPRIL MALEATE 5 MG TABLET?
Since Sep 28, 2022, the NADAC for ENALAPRIL MALEATE 5 MG TABLET has ranged from a low of $0.0693 (May 22, 2024) to a high of $0.1252 (Nov 16, 2022), with a median of $0.0790 per EA.
Are there cheaper alternatives to ENALAPRIL MALEATE 5 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENALAPRIL MALEATE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ENALAPRIL MALEATE 5 MG TABLET?
ENALAPRIL MALEATE 5 MG TABLET (NDC 43547054611) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.